Navigation Links
XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation
Date:11/17/2011

f blepharospasm, in 21 countries for the treatment of cervical dystonia (spasmodic torticollis), and in 17 countries for post-stroke spasticity of the upper limb (XEOMIN® is not approved for the treatment of spasticity in the U.S.). Due to unit differences in the LD50 assay, XEOMIN® units are specific to XEOMIN®. Therefore unit doses recommended for XEOMIN® are not interchangeable with those for other preparations of Botulinum toxin. Comparative clinical study results suggest that XEOMIN® and the comparator product containing conventional Botulinum toxin type A complex (900 kD) are of equal potency when used with a dosing conversion ratio of 1:1.

XEOMIN® is the only botulinum toxin product that does not require refrigeration during transport or storage.

XEOMIN® is available in 50 and 100 unit vials. The 50 unit vial helps facilitate flexible dosing and offers reduced product wastage as well as cost savings.

Merz Pharmaceuticals GmbH (www.merz.com):

Merz Pharmaceuticals, a member of the Merz Pharma Group of companies, is an innovative and international specialty healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. In addition to developing XEOMIN®, the company has developed memantine (Namenda®, Memary®, Axura®, Ebixa®) - the first drug for the treatment of moderate to severe Alzheimer's disease, which is marketed by Forest in the US, Daiichi-Sankyo in Japan, and Merz/Lundbeck in Europe and rest of the world. The company also focuses on the development of innovative therapies within the therapeutic areas of hepatology, metabolic diseases and dermatology.

XEOMIN® is a registered trademark of Merz Pharma GmbH & Co KGaA.


'/>"/>
SOURCE Merz Pharmaceuticals GmbH
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
2. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
3. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
5. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
6. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
7. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
8. New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
9. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
10. Positive Results from Phase 2 Trial of Mesoblasts Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
11. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... devices are artificial implants used to replace, augment, ... used in a wide range of applications including ... These implants are made of different materials such ... analysts forecast the global implantable medical devices market ...
(Date:9/2/2015)... -- About Neuroendovascular Coil A ... and ruptured brain aneurysm (a weakened area in ... as an endovascular coiling or endovascular embolization. During ... flow in an aneurysm. The endovascular coiling treatment ... interventional neuroradiologist using fluoroscopic imaging guidance. Neuroendovascular coils ...
(Date:9/2/2015)... -- About Chronic Lymphocytic Leukemia Chronic ... production of lymphocytes. It has been observed that the ... to other parts of the body. This leukemia is ... buildup of the cancerous cells. During the course of ... and lymph nodes. The course of the disease is ...
Breaking Medicine Technology:Global Implantable Medical Devices Market 2015-2019 2Global Neuroendovascular Coil Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3
...  Premier Research Group announces the appointment of Susan ... Vice President, Clinical Development. In this position, Dr. ... developing the company,s clinical trial management services provided ... industry knowledge and proven leadership skills will be ...
...  LIQUENT, Inc. the global leader in regulatory information ... LIQUENT,s XEVMPD Educational Series and Data Assessment tool. ... the July 2012 deadline for submitting product information ... LIQUENT,s XEVMPD Educational Series is ...
Cached Medicine Technology:Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development 2LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool 2
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... robust distribution channels and efficient customer and technical support services to promote LodonalTM ... approved 90-day Bridging trial evaluating the efficacy and safety of the product. , ...
(Date:9/2/2015)... ... September 03, 2015 , ... Leah Binder, MA, MGA, ... influential leaders in healthcare, will offer the keynote address at the upcoming meeting ... 2015, in Palm Harbor, Florida, at the Innisbrook Resort and Golf Club. For ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 03, 2015 ... ... stacks of nominations to determine who among America’s policymakers, public servants, activists, corporate ... on the nation’s health care. This year, that process led the magazine to ...
(Date:9/2/2015)... (PRWEB) , ... September 02, ... ... the 2015 Warrior-Family Symposium (WFS), cosponsored by the Military Officers Association of ... During the event, "Our Nation's Military: Caring For Our Own,” expert panelists ...
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... working to expand their fleet of truly superb luxury vehicles based on which of ... are pleased to announce the latest step forward in pursuit of this goal: a ...
Breaking Medicine News(10 mins):Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2
... with demand. Two experts in this weeks BMJ debate whether ... there is evidence to the contrary is the answer. ... support organ donation, yet only 23% have registered their wish ... at the British Medical Association. ,Research indicates that ...
... robotic technology may improve survival rates for prostate ... Thomas Jefferson University Hospitals multidisciplinary Genitourinary (GU) cancer ... 21, 2007 at the annual American Urological Society ... that performing a laparoscopic radical prostatectomy (LRP) with ...
... 10-fold over the past 40 years in England, owing to ... finds research published ahead of print in the British ... wide geographical variation in rates suggest that the NHS is ... and training, say the authors. ,The research team ...
... Researchers at Jefferson Medical College have shown that capsule ... small bowel Crohns disease in children. The technology has ... more than five years to diagnose unexplained abdominal bleeding ... is not much bigger than a vitamin pill and ...
... In a move to improve global public health, Weill ... heart disease drug onto the World Health Organization's ... guideline for developing countries to choose which high-priority drugs ... ,Students from Weill Cornell's chapter of Universities Allied for ...
... young to speak or crawl, but they can certainly tell ... with only visual cues. ,Researcher Whitney Weikum ... able to discern when a different language is spoken by ... face movements. ,The findings suggest that babies growing ...
Cached Medicine News:Health News:Is Presumed Consent the Answer to Organ Shortages? 2Health News:Robotic Surgery May Improve Survival Rate For Prostate Cancer Patients 2Health News:NHS Oversupplied With Cataract Surgery, Say Doctors 2Health News:Medical College Students Help Change Global Health Policy 2Health News:Even at Four Months, Babies can Tell When Speakers Switch Languages 2
Diareader ELX800G...
Plate Reader is an eight channel photometer for the sequential and simultaneous reading of micro-plate strips with 96 wells. High technology, user friendly, powerful and reliable....
... certified microstrip reader. Stat fax 303 ... to use with step-by-step prompting and ... other programming enhancements. On-board software calculates ... & a variety of cutoff options. ...
Iems Incubator/Shaker expansion module for 2 module incubator/shaker. high performance microplate incubator and orbital shaker. It's superior temperature control and efficient orbital shaking reduce ...
Medicine Products: